Featured Research

from universities, journals, and other organizations

Endothelin Receptor May Play Role In Sickle Cell Pain

Date:
September 13, 2009
Source:
American Physiological Society
Summary:
Endothelin may play a role in the pain of sickle cell disease because of a change in the endothelin B receptor. The activated receptor releases endorphins to help alleviate pain. Males who experience repeated pain may not have as much of the receptor and therefore do not release as much of the endorphins.

Agonizing physical pain, known as vaso-occlusive pain, can afflict children who have sickle cell disease (SCD). In some cases infants as young as two months of age suffer vaso-occlusive pain so severe that opiate medications and hospitalizations are their only relief. Researchers believe vaso-occlusion is caused by a blockage of the blood vessels that occurs when sickle shaped red cells attempt to pass through the round blood vessels. How vaso-occulsion leads to pain, and its impact on males and females are still unknown.

A University of South Carolina research team suggests that a naturally occurring chemical in the body, endothelin (ET), may play a role.

ET is produced by most tissues in the body and is highly concentrated in blood vessels. It causes blood vessels to contract, which contributes to pain. ET is the most potent blood vessel constrictor currently known. Characterized by a molecular structure similar to snake venom, ET can pack the punch of a bee sting.

Researchers Sarah Sweitzer, Federico Perez and Alvin McKelvy, Department of Pharmacology, Physiology and Neuroscience, University of South Carolina, Columbia have conducted several studies involving ET and vaso-occlusion pain. They are presenting an update of their work, “Sexually Dimorphic Nociceptive Priming by Endothelin: Involvement of the Endothelin B Receptor,” as part of the 11th International Conference on Endothelin being held September 9-12, 2009 in Montreal, CN. The program is being sponsored by the American Physiological Society.

Pain Early and Later in Life: Two-Part Study

The study was conducted in two parts. During phase I, 50 SCD+ adolescents (male and females between ages 8-18) were studied at the university’s Children’s Cancer and Blood Disorder Center. During the youngsters’ routine visits researchers videotaped the participants during the needle stick blood draw process and asked the participants to rate their pain level during the blood draw. The scoring system used emoticons that indicated pain levels between 0-10. The blood was then analyzed for the presence of endothelin, which was found to increase with the child’s increasing pain

In phase II the team constructed an animal model using endothelin that allowed them to control the age at first vaso-occlusive pain and the effect of repeated vaso-occlusive events on subsequent pain events.

Endothelin was administered to young rats seven days after birth and again on day 11 to model repeated painful vaso-occlusive type episodes. A different group experienced its first ET-1 exposure 11 days after birth. The two groups were compared.

Males More Sensitized to Pain

In the animal model the researchers found:

  • Males had a greater pain response if they had been “primed” to pain by a first exposure to ET-1. Moreover, their pain radiated virtually throughout the body rather than being confined to the localized area of the pain experience.
  • By contrast, females had a lower pain response if they had been primed, meaning they were de-sensitized to pain after a first exposure to ET-1. Further, unlike the males, female desensitization was localized rather than widespread.

The data from the clinic study showed similar results:

  • Male SCD patients in the clinic study were sensitized to pain after “priming” whereas female SCD patients were de-sensitized.

Role of Endothelin, Endorphins and Hormones

According to Sweitzer, these findings may be due to a change in the endothelin B receptor (ETBR). This receptor is important in the body’s internal ability to control pain. That is because ETBR resides in many places within the body, including the cells that make up skin.

When the receptor is activated, it releases endorphins (the body’s natural opiate) throughout the body. “We are finding that the males who experience repeated pain do not have as much of the receptor and therefore do not release as much of the endorphins,” Sweitzer explained.

Conversely, the team has found that females have more of the ETB receptor. “Females experience better pain control and have more of the receptor. This juxtaposition may help explain sensitivity by gender. The difference in the endothelin receptor may help explain why we are finding males more sensitized to pain.”


Story Source:

The above story is based on materials provided by American Physiological Society. Note: Materials may be edited for content and length.


Cite This Page:

American Physiological Society. "Endothelin Receptor May Play Role In Sickle Cell Pain." ScienceDaily. ScienceDaily, 13 September 2009. <www.sciencedaily.com/releases/2009/09/090910091329.htm>.
American Physiological Society. (2009, September 13). Endothelin Receptor May Play Role In Sickle Cell Pain. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2009/09/090910091329.htm
American Physiological Society. "Endothelin Receptor May Play Role In Sickle Cell Pain." ScienceDaily. www.sciencedaily.com/releases/2009/09/090910091329.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins